Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab combinations in elderly NSCLC
NCT00456261Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Mar 2007
- Primary completion
- Feb 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in non-small cell lung cancer (NSCLC), sponsored by SCRI Development Innovations. Started Mar 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00456261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00456261.